Diabetes in Postmenopause: Different Influence on Bone Mass According to Age and Disease Duration

Abstract

Objective: Studies addressing the influence of diabetes mellitus on bone metabolism have yielded conflicting results. The aim of the present study is to investigate the bone mineral density (BMD) status of postmenopausal diabetic women with different ages or diabetes duration.

Methods: Two hundred postmenopausal women with type 2 diabetes (DM) and 800 postmenopausal healthy women (PMP), serving as control subjects, were studied. Subjects were divided into either 6 groups according to 5 year age segments, or 6 groups according to 5 year segments of diabetes duration. BMD was measured at the femoral neck and at the trochanter major with dual energy X-ray absorptiometry.

Results: Diabetic women studied as a whole, exhibited significantly higher BMD values compared to healthy postmenopausal women at both femoral neck and trochanter. Diabetic women of 48–53, 53–58, 58–63 and 63–68 age groups had significantly higher BMD values than the respective control groups, whereas BMD values of DM 73–78 were significantly lower compared to the PMP 73–78 group at both anatomic sites. When the same diabetic women were divided according to diabetes duration (DUR), groups DUR 6–10 and DUR 11–15 exhibited significantly higher BMD values at both anatomic sites compared to control groups. In contrast, BMD values of group DUR 21–25 were significantly lower only at the femoral neck.

Conclusions: Type 2 diabetes mellitus’ influence on bone metabolism seems to depend on the patient's disease duration and age. The initial positive effect on bone mass appears to be ameliorated as age or disease duration advance. Studies concerning type 2 diabetes and bone mass should take these parameters into account.

Key words

diabetes - osteoporosis - bone mineral density - menopause

References

• 1 Albright F, Reifenstein EC. Parathyroid glands and metabolic bone disease: selected studies. Williams & Wilkins, Baltimore 1948
• 2 Barrett-Connor E, Kritz-Silverstein D. Does hyperinsulinemia preserve bone?.  Diabetes Care. 1996;  19 1388-1392
• 3 Bouillon R. Diabetic bone disease.  Calcif Tissue Int. 1991;  49 155-160
• 4 Dennison EM, Syddall HE, Aihie SA, Craighead S, Phillips DI, Cooper C. Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance?.  Diabetologia. 2004;  47 1963-1968
• 5 Greendale GA, Barrett-Connor E, Edelstein S, Ingles S, Haile R. Lifetime leisure exercise and osteoporosis. The Rancho Bernardo study.  Am J Epidemiol. 1995;  141 951-959
• 6 Hadjidakis D, Kokkinakis E, Giannopoulos G, Merakos G, Raptis SA. Bone mineral density of vertebrae, proximal femur and os calcis in normal Greek subjects as assessed by dual-energy X-ray absorptiometry: comparison with other populations.  Eur J Clin Invest. 1997;  27 219-227
• 7 Hadjidakis DJ, Raptis AE, Sfakianakis M, Mylonakis A, Raptis SA. Bone mineral density of both genders in type 1 diabetes according to bone composition.  J Diabetes Complications. 2006;  20 302-307
• 8 Hanley DA, Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, Prior JC, Pickard L, Murray TM, Anastassiades T, Kirkland S, Joyce C, Joseph L, Papaioannou A, Jackson SA, Poliquin S, Adachi JD. Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study.  J Bone Miner Res. 2003;  18 784-790
• 9 Hannan MT, Felson DT, wson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study.  J Bone Miner Res. 2000;  15 710-720
• 10 Heath  III  H, Melton  III  LJ, Chu CP. Diabetes mellitus and risk of skeletal fracture.  N Engl J Med. 1980;  303 567-570
• 11 Isaia G, Bodrato L, Carlevatto V, Mussetta M, Salamano G, Molinatti GM. Osteoporosis in type II diabetes.  Acta Diabetol Lat. 1987;  24 305-310
• 12 Ishida H, Seino Y, Matsukura S, Ikeda M, Yawata M, Yamashita G, Ishizuka S, Imura H. Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes.  Metabolism. 1985;  34 797-801
• 13 Jehle PM, Jehle DR, Mohan S, Bohm BO. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients.  J Endocrinol. 1998;  159 297-306
• 14 Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR. Rate of bone loss is associated with mortality in older women: a prospective study.  J Bone Miner Res. 2000;  15 1974-1980
• 15 Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk.  Lancet. 2002;  359 1929-1936
• 16 Krakauer JC, MacKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes.  Diabetes. 1995;  44 775-782
• 17 Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women.  Diabetes Care. 2005;  28 2926-2932
• 18 Lunt M, Masaryk P, Scheidt-Nave C, Nijs J, Poor G, Pols H, Falch JA, Hammermeister G, Reid DM, Benevolenskaya L, Weber K, Cannata J, O'Neill TW, Felsenberg D, Silman AJ, Reeve J. The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study.  Osteoporos Int. 2001;  12 688-698
• 19 Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women.  Diabetes Care. 2001;  24 1192-1197
• 20 Raskin P, Stevenson MR, Barilla DE, Pak CY. The hypercalciuria of diabetes mellitus: its amelioration with insulin.  Clin Endocrinol (Oxf). 1978;  9 329-335
• 21 Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR. Older women with diabetes have an increased risk of fracture: a prospective study.  J Clin Endocrinol Metab. 2001;  86 32-38
• 22 Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold KR, Resnick HE, Shorr RI, Nevitt MC, Black DM, Cauley JA, Cummings SR, Harris TB. Diabetes and bone loss at the hip in older black and white adults.  J Bone Miner Res. 2005;  20 596-603
• 23 Stolk RP, Daele PL Van, Pols HA, Burger H, Hofman A, Birkenhager JC, Lamberts SW, Grobbee DE. Hyperinsulinemia and bone mineral den-sity in an elderly population: The Rotterdam Study.  Bone. 1996;  18 545-549
• 24 Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, Tylavsky FA, de RN, Harris TB, Newman AB. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study.  Arch Intern Med. 2005;  165 1612-1617
• 25 Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Zmuda JM, Bauer DC, Tylavsky FA, de RN, Harris TB, Newman AB. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study.  J Bone Miner Res. 2004;  19 1084-1091
• 26 Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes.  Diabetes Care. 1999;  22 1196-1200
• 27 Daele PL van, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, Birkenhager JC, Pols HA. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study.  Ann Intern Med. 1995;  122 409-414
• 28 Weinstock RS, Goland RS, Shane E, Clemens TL, Lindsay R, Bilezikian JP. Bone mineral density in women with type II diabetes mellitus.  J Bone Miner Res. 1989;  4 97-101
• 29 Yendt ER, Cohanim M, Jarzylo S, Jones G, Rosenberg G. Reduced creatinine clearance in primary osteoporosis in women.  J Bone Miner Res. 1993;  8 1045-1052
• 30 Yki-Jarvinen H. Pathogenesis of non-insulin-dependent diabetes mellitus.  Lancet. 1994;  343 91-95

Correspondence